Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    p07037
Show Display Options
Rank Status Study
1 Terminated An Active-Controlled Extension Study to P04938 and P07037 (P06153 AM3)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease
Interventions: Drug: Preladenant;   Drug: Rasagiline;   Drug: Placebo to preladenant;   Drug: Placebo to rasagiline
2 Completed
Has Results
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease;   Idiopathic Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.